(Q40714436)

23 September 2017

1 reference

title

Prevention and management of the adverse effects associated with immunosuppressive therapy (English)

1 reference

23 September 2017

S J Rossi

1

1 reference

23 September 2017

T J Schroeder

series ordinal

2

1 reference

23 September 2017

S Hariharan

series ordinal

3

1 reference

23 September 2017

M R First

series ordinal

4

1 reference

23 September 2017

publication date

1 August 1993

1 reference

23 September 2017

1 reference

23 September 2017

volume

9

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

104-131

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199309020-00004

23 September 2017

exact match

0 references

cites work

In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody

1 reference

12 December 2020

Calcium channel blockers for kidney protection

1 reference

12 December 2020

Post-transplant hypertension

1 reference

12 December 2020

Heterologous antilymphocyte serum: a review

1 reference

12 December 2020

Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience

1 reference

12 December 2020

Differences in antibody formation to OKT3 between kidney and heart transplantation recipients

1 reference

12 December 2020

Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome

1 reference

12 December 2020

Tapering or discontinuing cyclosporine for financial reasons--a single-center experience

1 reference

12 December 2020

Osteonecrosis and fractures following renal transplantation

1 reference

12 December 2020

Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins?

1 reference

12 December 2020

Hyperkalaemia in cyclosporin-treated renal allograft recipients

1 reference

12 December 2020

The prostaglandin E1 analog misoprostol reverses acute cyclosporine nephrotoxicity

1 reference

12 December 2020

A pilot study to assess the ability of an orally available selective thromboxane synthase inhibitor to improve renal function in cyclosporine-treated renal transplant recipients

1 reference

12 December 2020

Cyclosporine-induced hyperuricemia and gout

1 reference

12 December 2020

The complications of antilymphocyte therapy

1 reference

12 December 2020

Inhibition of anti-OKT3 antibody generation by cyclosporine--results of a prospective randomized trial

1 reference

12 December 2020

Cyclosporine-associated central nervous system toxicity after renal transplantation

1 reference

12 December 2020

Ocular complications in renal transplant recipients

1 reference

12 December 2020

Withdrawal of steroid immunosuppression in renal transplant recipients

1 reference

12 December 2020

Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signaling in mesangial cells

1 reference

12 December 2020

Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts

1 reference

12 December 2020

Prevention of cyclosporine-induced nephrotoxicity with pentoxifylline

1 reference

12 December 2020

The human immune response to the OKT3 monoclonal antibody is oligoclonal

1 reference

12 December 2020

Clinical approach to viral and fungal infections in the renal transplant patient

1 reference

12 December 2020

The role of cachectin/TNF in endotoxic shock and cachexia

1 reference

12 December 2020

Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil

1 reference

12 December 2020

In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids

1 reference

12 December 2020

Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure

1 reference

12 December 2020

The therapeutic use of azathioprine in renal transplantation

1 reference

12 December 2020

1 reference

12 December 2020

Cyclosporine-induced renal dysfunction in human renal allograft recipients.

1 reference

12 December 2020

The effects of dietary supplementation with fish oil on renal function in cyclosporine-treated renal transplant recipients.

1 reference

12 December 2020

Influence of ciclosporin A on renal tubular function after kidney transplantation

1 reference

12 December 2020

Withdrawal of steroids after renal transplantation--clinical predictors of outcome

1 reference

12 December 2020

Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification

1 reference

12 December 2020

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

1 reference

12 December 2020

Late mortality and morbidity in recipients of long-term renal allografts

1 reference

12 December 2020

Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number

1 reference

12 December 2020

Evaluation of intravenous route for administration of antilymphocyte globulins in humans

1 reference

12 December 2020

Mechanism of cyclosporine-induced hypertension

1 reference

12 December 2020

Elective cyclosporine withdrawal after renal transplantation. A meta-analysis

1 reference

12 December 2020

OKT3: First-dose safety and success

1 reference

12 December 2020

Influence of cyclosporine on posttransplant blood pressure response

1 reference

12 December 2020

Verapamil improves the outcome after cadaver renal transplantation

1 reference

12 December 2020

Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide

1 reference

12 December 2020

Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans.

1 reference

12 December 2020

Complications and monitoring of OKT3 therapy

1 reference

12 December 2020

Hyperuricemia after renal transplantation

1 reference

12 December 2020

Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA.

1 reference

12 December 2020

Complications related to the route of Minnesota antilymphoblast globulin administration in renal transplant recipients

1 reference

12 December 2020

Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia

1 reference

12 December 2020

Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-γ, interleukin 3 and interleukin 6 release after triggering of the CD33/T cell receptor activation pathway

1 reference

12 December 2020

A review of assay methods for cyclosporin. Clinical implications

1 reference

12 December 2020

Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids

1 reference

12 December 2020

Cyclosporine nephrotoxicity

1 reference

12 December 2020

Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine

1 reference

12 December 2020

Life-threatening thrombocytopenia complicating antithymocyte globulin therapy for acute kidney transplant rejection. Evidence of in situ immune complex formation on the platelet surface

1 reference

12 December 2020

Antilymphocyte globulin: a clinical transplantation research opportunity

1 reference

12 December 2020

Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone

1 reference

12 December 2020

Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels

1 reference

12 December 2020

Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study

1 reference

12 December 2020

Serial analysis of circulating immune complexes, complement, and antithymocyte globulin antibodies in heart transplant recipients

1 reference

12 December 2020

Mechanisms of cyclosporine-induced hypertension

1 reference

12 December 2020

Complications associated with immunosuppressive therapy and their management

1 reference

12 December 2020

Antimurine antibody formation following OKT3 therapy

1 reference

12 December 2020

Cyclosporine-induced sympathetic activation and hypertension after heart transplantation

1 reference

12 December 2020

Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients

1 reference

12 December 2020

Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity

1 reference

12 December 2020

Does calcium antagonist improve established early ciclosporin nephrotoxicity after renal transplantation?

1 reference

12 December 2020

Long-term effects of cyclosporine on renal function in organ transplant recipients.

1 reference

12 December 2020

Cyclosporine-associated central neurotoxicity after heart transplantation

1 reference

12 December 2020

Metabolism and pulmonary toxicity of cyclophosphamide

1 reference

12 December 2020

Prevention of Cyclosporine A-Induced Vascular Toxicity by Pentoxifylline

1 reference

12 December 2020

Induction of thromboses within renal grafts by high-dose prophylactic OKT3

1 reference

12 December 2020

Acute hyperuricemic nephropathy and renal failure after transplantation

1 reference

12 December 2020

Evidence of involvement of tumor necrosis factor in adverse reactions during treatment of kidney allograft rejection with antithymocyte globulin

1 reference

12 December 2020

Cyclosporine (Cy) monotherapy after cadaveric renal transplantation

1 reference

12 December 2020

Evidence that calcium channel blockade prevents cyclosporine-induced exacerbation of renal ischemic injury

1 reference

12 December 2020

Effects of cyclosporine therapy on plasma lipoprotein levels.

1 reference

12 December 2020

OKT3 treatment of steroid-resistant renal allograft rejection.

1 reference

12 December 2020

A comparison of alternate day and daily steroid therapy in children following renal transplantation

1 reference

12 December 2020

The adverse impact of cyclosporine on serum lipids in renal transplant recipients.

1 reference

12 December 2020

Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group

1 reference

12 December 2020

Cancer chemotherapy after solid organ transplantation

1 reference

12 December 2020

Successful withdrawal of corticosteroids in heart transplantation

1 reference

12 December 2020

Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy

1 reference

12 December 2020

Cellular and molecular mechanisms of cyclosporin nephrotoxicity

1 reference

12 December 2020

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

12 December 2020

Pathogenesis of cyclosporine-induced hypomagnesemia

1 reference

12 December 2020

The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation

1 reference

12 December 2020

OKT3-induced cytokine-release syndrome: prevention effect of anti-tumor necrosis factor monoclonal antibody.

1 reference

12 December 2020

Comparison of antimouse and antihorse antibody production during the treatment of allograft rejection with OKT3 or antithymocyte globulin

1 reference

12 December 2020

Urological complications of cyclophosphamide

1 reference

12 December 2020

Prevention of delayed graft function by diltiazem and iloprost.

1 reference

12 December 2020

Cerebrospinal fluid inflammation during OKT3 therapy.

1 reference

12 December 2020

Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejection

1 reference

12 December 2020

The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients.

1 reference

12 December 2020

Hemorrhagic cystitis: a review

1 reference

12 December 2020

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

12 December 2020

Activation of K+ channel and inhibition of Na(+)-K+ ATPase of human erythrocytes by cyclosporine: possible role in hyperpotassemia in kidney transplant recipients.

1 reference

12 December 2020

1 reference

12 December 2020

Adult respiratory distress syndrome related to antilymphocyte globulin therapy

1 reference

12 December 2020

Reactivities to horse anti-lymphocyte globulin. II. Serum sickness nephritis with complement alterations in man.

1 reference

12 December 2020

Enisoprost in renal transplantation. The Enisoprost Renal Transplant Study Group

1 reference

12 December 2020

Hyperlipidemia after organ transplantation

1 reference

12 December 2020

Lovastatin treatment of hypercholesterolemia in renal transplant recipients

1 reference

12 December 2020

Probable azathioprine hepatotoxicity: a case report

1 reference

12 December 2020

Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone

1 reference

12 December 2020

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

12 December 2020

Growth hormone in renal transplantation--the mode of action, animal studies, and clinical use

1 reference

12 December 2020

Raised serum tumour necrosis factor in delayed antilymphocyte globulin adverse reactions

1 reference

12 December 2020

Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I

1 reference

12 December 2020

Antibody formation following administration of antilymphocyte serum

1 reference

12 December 2020

Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent

1 reference

12 December 2020

Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.

1 reference

12 December 2020

Reversible cholestasis with bile duct injury following azathioprine therapy. A case report

1 reference

12 December 2020

The effect of the thromboxane receptor antagonist GR32191B on cyclosporine-induced nephrotoxicity

1 reference

12 December 2020

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

1 reference

12 December 2020

Does nifedipine ameliorate cyclosporin A nephrotoxicity?

1 reference

12 December 2020

Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity

1 reference

12 December 2020

Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions

1 reference

12 December 2020

Clinical development of Orthoclone OKT3.

1 reference

12 December 2020

Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patients

1 reference

12 December 2020

Azathioprine and severe bone marrow depression

1 reference

12 December 2020

Musculoskeletal pain in renal-transplant recipients

1 reference

12 December 2020

Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study

1 reference

12 December 2020

Cyclosporine-induced gingival overgrowth

1 reference

12 December 2020

Cyclophosphamide toxicity. Characterising and avoiding the problem

1 reference

12 December 2020

Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans

1 reference

12 December 2020

Pentoxifylline reduces the first-dose reactions following OKT3.

1 reference

12 December 2020

Cyclosporine nephrotoxicity: pathogenesis, prophylaxis, therapy, and prognosis

1 reference

12 December 2020

Cyclosporine, low-density lipoprotein, and cholesterol

1 reference

12 December 2020

Effects of Cyclosporin A and Low Dosages of Steroid on Posttransplantation Diabetes in Kidney Transplant Recipients

1 reference

12 December 2020

Hyperuricemia and gout among heart transplant recipients receiving cyclosporine

1 reference

12 December 2020

OKT3 first-dose reaction: association with T cell subsets and cytokine release

1 reference

12 December 2020

Cutaneous manifestations of serum sickness in patients receiving antithymocyte globulin

1 reference

12 December 2020

Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use

1 reference

12 December 2020

Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome--dosage and kinetics prerequisites

1 reference

12 December 2020

Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression

1 reference

12 December 2020

Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effects

1 reference

12 December 2020

Incidence of osteonecrosis after renal transplantation

1 reference

12 December 2020

Cancers following cyclosporine therapy

1 reference

12 December 2020

The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporine-treated rats

1 reference

12 December 2020

Cyclosporine alone or in combination with prednisone in cadaveric renal transplantation

1 reference

12 December 2020

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

1 reference

12 December 2020

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

1 reference

12 December 2020

OKT3-associated adverse reactions: mechanistic basis and therapeutic options.

1 reference

12 December 2020

Azathioprine hepatotoxicity after liver transplantation.

1 reference

12 December 2020

The effect of indomethacin on the febrile response following OKT3 therapy

1 reference

12 December 2020

Cardiovascular collapse following orthoclone OKT3 administration: a case report

1 reference

12 December 2020

Anaphylactic shock after retreatment with OKT3 monoclonal antibody

1 reference

12 December 2020

The effects of pravastatin on hyperlipidemia in renal transplant recipients

1 reference

12 December 2020

Beneficial effects of heterologous antilymphoid globulins in renal transplantation: one "believer's" view

1 reference

12 December 2020

Cyclosporine promotes glomerular endothelin binding in vivo

1 reference

12 December 2020

10.2165/00002018-199309020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

23 September 2017

1034631141

0 references

1 reference